GSDMB: A novel, independent prognostic marker and potential new therapeutic target in clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

GSDMB: A novel, independent prognostic marker and potential new therapeutic target in clear cell renal cell carcinoma

Published:2024-01-05 Issue:2 Volume:27 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Huang Hongshuang¹,Chen Ru²,Deng Xinxi³,Wang Jie⁴,Chen Jianhui⁵

Affiliation:

1. Department of Urology, The Affiliated Hospital of Putian University, Putian, Fujian 351100, P.R. China

2. Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330000, P.R. China

3. Department of Urology, Jiujiang No. 1 People's Hospital, Jiujiang, Jiangxi 332000, P.R. China

4. Department of Ultrasound, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China

5. Department of Urology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350000, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference53 articles.

1. Epidemiology of renal cell carcinoma;Capitanio;Eur Urol,2019

2. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022

3. Papillary renal cell carcinoma: A review of the current therapeutic landscape;Courthod;Crit Rev Oncol Hematol,2015

4. Early ultrasound detection of renal tumors in patients with end stage renal disease in dialysis;Bellido;Arch Esp Urol,2007

5. Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: A meta-analysis of randomized controlled trials;Tunio;Ann Oncol,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP